REYON Pharmaceutical Co., Ltd. (KRX: 102460)
South Korea
· Delayed Price · Currency is KRW 13,700
-160 (-1.15%)
Oct 8, 2024, 3:30 PM KST
REYON Pharmaceutical Ratios and Metrics
Market cap in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Oct '24 Oct 7, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Market Capitalization | 253,106 | 303,360 | 384,347 | 631,111 | 390,433 | 264,446 | Upgrade
|
| Market Cap Growth | -17.74% | -21.07% | -39.10% | 61.64% | 47.64% | 15.07% | Upgrade
|
| Enterprise Value | 468,384 | 498,164 | 550,681 | 726,725 | 401,156 | 228,088 | Upgrade
|
| Last Close Price | 13800.00 | 16540.00 | 21446.14 | 34975.15 | 21584.40 | 15173.35 | Upgrade
|
| PE Ratio | - | 84.82 | 52.67 | 114.67 | 95.61 | 51.72 | Upgrade
|
| PS Ratio | 1.72 | 2.01 | 2.50 | 4.42 | 3.00 | 2.01 | Upgrade
|
| PB Ratio | 1.03 | 1.22 | 1.55 | 2.57 | 1.70 | 1.19 | Upgrade
|
| P/FCF Ratio | -11.25 | -15.00 | -7.06 | -5.99 | -8.18 | -4.19 | Upgrade
|
| P/OCF Ratio | 94.09 | 35.09 | 44.03 | 54.01 | 84.89 | -21.71 | Upgrade
|
| EV/Sales Ratio | 3.14 | 3.30 | 3.57 | 5.09 | 3.09 | 1.73 | Upgrade
|
| EV/EBITDA Ratio | 102.51 | 76.00 | 61.31 | 117.02 | 64.51 | 21.30 | Upgrade
|
| EV/EBIT Ratio | 248.52 | 281.00 | 123.80 | 470.45 | 242.52 | 34.44 | Upgrade
|
| EV/FCF Ratio | -21.08 | -24.63 | -10.12 | -6.90 | -8.41 | -3.61 | Upgrade
|
| Debt / Equity Ratio | 0.90 | 0.91 | 0.85 | 0.85 | 0.26 | 0.15 | Upgrade
|
| Debt / EBITDA Ratio | 36.02 | 34.33 | 23.40 | 33.38 | 9.56 | 3.14 | Upgrade
|
| Debt / FCF Ratio | -10.05 | -11.13 | -3.86 | -1.97 | -1.25 | -0.53 | Upgrade
|
| Asset Turnover | 0.30 | 0.31 | 0.32 | 0.36 | 0.44 | 0.46 | Upgrade
|
| Inventory Turnover | 2.23 | 2.25 | 2.60 | 2.35 | 2.22 | 2.59 | Upgrade
|
| Quick Ratio | 0.36 | 0.51 | 1.63 | 2.91 | 1.83 | 3.21 | Upgrade
|
| Current Ratio | 0.65 | 0.79 | 2.27 | 3.47 | 2.42 | 3.94 | Upgrade
|
| Return on Equity (ROE) | -0.04% | 1.44% | 3.02% | 2.33% | 1.70% | 2.21% | Upgrade
|
| Return on Assets (ROA) | 0.23% | 0.23% | 0.58% | 0.24% | 0.35% | 1.44% | Upgrade
|
| Return on Capital (ROIC) | 0.24% | 0.24% | 0.61% | 0.26% | 0.38% | 1.61% | Upgrade
|
| Earnings Yield | -0.04% | 1.18% | 1.93% | 0.88% | 0.98% | 1.87% | Upgrade
|
| FCF Yield | -8.78% | -6.67% | -14.15% | -16.68% | -12.22% | -23.87% | Upgrade
|
| Dividend Yield | 1.08% | 0.91% | 0.70% | 0.71% | 0.93% | 2.26% | Upgrade
|
| Payout Ratio | 0.00% | 76.41% | 61.39% | 62.56% | 150.47% | 167.08% | Upgrade
|
| Buyback Yield / Dilution | 0.90% | -0.46% | -3.03% | -4.05% | -1.01% | 0.80% | Upgrade
|
| Total Shareholder Return | 1.99% | 0.44% | -2.33% | -3.34% | -0.09% | 3.07% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.